Yüklüyor......
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy...
Kaydedildi:
| Yayımlandı: | BJPsych Bull |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Royal College of Psychiatrists
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706192/ https://ncbi.nlm.nih.gov/pubmed/26755968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/pb.bp.114.048793 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|